12.3 C
New York
Sunday, April 2, 2023

Is Becton Dickinson and Company (NYSE: BDX) No Longer A Good Investment?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Becton Dickinson and Company (BDX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.55, or 0.23%, to $236.68. The Becton Dickinson and Company has recorded 45,244 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed BD to Present at Barclays Global Healthcare Conference.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Stocks Info

Becton Dickinson and Company is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. At the end of the last regular session, the stock closed at $236.13 and fluctuated between $238.23 as its day high and $234.92 as its day low. The current market capitalization of Becton Dickinson and Company is $65.99B. A total of 1.23 million shares were traded on the day, compared to an average of 1.17M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, BDX has seen 10 BUY and 3 SELL insider trades, representing the acquisition of 8,480 and the disposition of 1,480 shares. Over the last 12 months, there were 39 BUYs and 25 SELLs from insiders. Insiders purchased 133,542 shares during that period but sold 66,562.

In the most recent transaction, Byrd Richard sold 1,421 shares of BDX for 248.60 per share on Feb 03. After the transaction, the EVP & President Interventional now owns 4,119 company shares. In a previous transaction on Aug 15, Polen Thomas E Jr sold 9,500 shares at 265.13 per share. BDX shares that Chairman, CEO and President owns now total 28,878.

Among the insiders who sold shares, Hickey David disposed of 475 shares on Aug 15 at a per-share price of $265.00. This resulted in the EVP & President, Life Sciences holding 3,331 shares of BDX after the transaction. In another insider transaction, Khichi Samrat S. sold 9,185 shares at $260.44 per share on Aug 09. Company shares held by the EVP and General Counsel now total 5,928.


It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Becton Dickinson and Company pays an annual dividend of $3.64, resulting in a dividend yield of 1.54%, and it has a price to earnings (P/E) ratio of 45.62. BDX’s most recent ex-dividend date was 3/9/2023 when it declared a $0.91 quarterly dividend that was paid in cash on 3/31/2023. Previously, the company paid the dividend on 12/30/2022 with an ex-dividend date of 12/8/2022. The BDX stock dividend was $0.91 per share in cash.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for BDX in the last 3 months, the mean price target is $274.00 with high estimates of $300.00 and low estimates of $245.00. In terms of 52-week highs and lows, BDX has a high of $277.29 and a low of $215.90.

As of this writing, BDX has an earnings estimate of $2.75 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $2.84 per share and a lower estimate of $2.7. The company reported an EPS of $2.75 in the last quarter, which was 0.40% higher than expectations of $2.74.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 17 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDX is Underweight with a score of 4.00. A total of 8 analysts rated the stock as Buy while 1 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles